Collegium Pharmaceutical Inc (COLL)

Cost of Revenue

$89.59M

Quarterly · Period ending: · USD

COLL logo

COLL Cost of Revenue

Latest reported$89.59M
COLL Quarterly Cost of Revenue ($0.00 → $89.59M)
High-resolution chart · PNG

COLL cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Collegium Pharmaceutical Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
89,586,000
76,274,000
77,071,000
80,190,000
79,616,000
80,433,000
83,661,000
62,507,000
54,470,000
53,467,000
55,115,000
56,398,000
61,720,000
67,365,000
79,831,000
68,174,000
71,185,000
35,255,000
28,695,000
32,730,000
32,703,000
32,123,000
31,979,000
30,983,000
29,694,000
37,524,000
49,088,000
46,754,000
48,654,000
49,164,000
29,726,000
46,007,000
46,838,000
43,106,000
1,094,000
553,000
577,000
371,000
184,000
29,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.